.30 Mar 2018 16:12
C4X started the search for a licensee for C4X-3256 in the middle of last year, attracting the attention of a number of potential partners. "There was interest from big pharma, but they all have other programs on the go. We chose Indivior because of how keen they are, and because of their specialist knowledge," said Dix.